Agency Information Collection Activities; Proposed eCollection, eComments Requested; New Proposed Collection Exempt Chemical Preparations Application, 22070-22071 [2021-08586]

Download as PDF 22070 Federal Register / Vol. 86, No. 78 / Monday, April 26, 2021 / Notices statement of the reasons why the Commission should grant such treatment. See 19 CFR 201.6. Documents for which confidential treatment by the Commission is properly sought will be treated accordingly. All information, including confidential business information and documents for which confidential treatment is properly sought, submitted to the Commission for purposes of this Investigation may be disclosed to and used: (i) By the Commission, its employees and Offices, and contract personnel (a) for developing or maintaining the records of this or a related proceeding, or (b) in internal investigations, audits, reviews, and evaluations relating to the programs, personnel, and operations of the Commission including under 5 U.S.C. Appendix 3; or (ii) by U.S. government employees and contract personnel,2 solely for cybersecurity purposes. All nonconfidential written submissions will be available for public inspection at the Office of the Secretary and on EDIS.3 This action is taken under the authority of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and of §§ 201.10 and 210.8(c) of the Commission’s Rules of Practice and Procedure (19 CFR 201.10, 210.8(c)). By order of the Commission. Issued: April 21, 2021. Lisa Barton, Secretary to the Commission. In accordance with 21 CFR 1301.34(a), this is notice that on March 15, 2021, Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Drug code Tetrahydrocannabinols .......... Methylphenidate ..................... Oxycodone ............................. Hydromorphone ..................... Hydrocodone .......................... Morphine ................................ Opium, Raw ........................... Oxymorphone ........................ Poppy Straw Concentrate ...... BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–827] Importer of Controlled Substances Application: Rhodes Technologies Drug Enforcement Administration, Department of Justice. ACTION: Notice of application. AGENCY: Rhodes Technologies has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the SUMMARY: 2 All contract personnel will sign appropriate nondisclosure agreements. 3 Electronic Document Information System (EDIS): https://edis.usitc.gov. 18:01 Apr 23, 2021 Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: Controlled substance [FR Doc. 2021–08654 Filed 4–23–21; 8:45 am] VerDate Sep<11>2014 issuance of the proposed registration on or before May 26, 2021. Such persons may also file a written request for a hearing on the application on or before May 26, 2021. Jkt 253001 Schedule 7370 1724 9143 9150 9193 9300 9600 9652 9670 I II II II II II II II II The company plans to import Opium, Raw (9600), and Poppy Straw Concentrate (9670) in order to bulk manufacture controlled substances in Active Pharmaceutical Ingredient (API) form. The company distributes the manufactured APIs in bulk to its customers. The company plans to import the other listed controlled substances for internal reference standards use only. The comparisons of foreign reference standards to the company’s domestically manufactured API will allow the company to export domestically manufactured API to foreign markets. William T. McDermott, Assistant Administrator. [FR Doc. 2021–08539 Filed 4–23–21; 8:45 am] BILLING CODE 4410–09–P PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–NEW] Agency Information Collection Activities; Proposed eCollection, eComments Requested; New Proposed Collection Exempt Chemical Preparations Application Drug Enforcement Administration, Department of Justice. ACTION: 60-Day notice. AGENCY: The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 60 days until June 25, 2021. FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Scott A. Brinks, Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362–3261. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information proposed to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other forms of information technology, e.g., permitting electronic submission of responses. SUMMARY: E:\FR\FM\26APN1.SGM 26APN1 22071 Federal Register / Vol. 86, No. 78 / Monday, April 26, 2021 / Notices Overview of This Information Collection 1. Type of Information Collection: New collection. 2. Title of the Form/Collection: Exempt Chemical Preparations Application. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: N/A. The applicable component within the Department of Justice is the Drug Enforcement Administration, Diversion Control Division. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Affected public: Business or other forprofit. Abstract: Pursuant to 21 U.S.C. 811(g)(3)(B), DEA (by delegation of authority from the Attorney General) may, by regulation, exempt from specific provisions of the Controlled Substances Act (CSA) any compound, mixture, or preparation containing any controlled substance, which is not for administration to a human being or animal, and which is packaged in a certain manner, so that as packaged it Labor category does not present any significant potential for abuse. In accordance with 21 CFR 1308.23(f), the Administrator (or the Deputy Assistant Administrator), at any time, may revoke or modify any exemption granted pursuant to 21 CFR 1308.23; modify or revoke the criteria by which exemptions are granted; and modify the scope of exemptions. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The below table presents information regarding the number of respondents, responses and associated burden hours. Number % of time Cost Chemist, GS–14, step 5 .............................................................................................................. Unit Chief, GS–14, step 5 ........................................................................................................... Section Chief, GS–15, step 5 ...................................................................................................... 3 1 1 30 5 1 $200,967 11,165 2,627 Total ...................................................................................................................................... ........................ ........................ 214,758 6. An estimate of the total public burden (in hours) associated with the proposed collection: DEA estimates that this collection takes 2,093 annual burden hours. If additional information is required please contact: Melody Braswell, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC 20530. Dated: April 21, 2021. Melody Braswell, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2021–08586 Filed 4–23–21; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Federal Bureau of Investigation [OMB Number 1110–0039] Agency Information Collection Activities; Proposed eCollection; eComments Requested; Revision of a Currently Approved Collection Bioterrorism Preparedness Act: Entity/ Individual Information Criminal Justice Information Services Division, Federal Bureau of Investigation (FBI), Department of Justice (DOJ). ACTION: 30-Day notice. AGENCY: The Criminal Justice Information Services (CJIS) Division, Federal Bureau of Investigation (FBI), Department of Justice (DOJ), will be SUMMARY: VerDate Sep<11>2014 18:01 Apr 23, 2021 Jkt 253001 submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for an additional 30 days until May 26, 2021. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and —Minimize the burden of the collection of information on those who are to respond, including through the use of PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: Revision of a currently approved collection. (2) Title of the Form/Collection: Federal Bureau of Investigation Bioterrorism Preparedness Act: Entity/ Individual Information. (3) Agency form number, if any, and the applicable component of the Department sponsoring the collection: Agency form number: FD–961 Sponsoring component: Criminal Justice Information Services Division, Federal Bureau of Investigation (FBI), Department of Justice (DOJ). (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: City, county, state, federal, individuals, business or other for profit, and not-for-profit institute. This collection is needed to receive names and other identifying information submitted by individuals requesting access to specific agents or toxins, and consult with appropriate official of the Department of Health and Human Services and the Department of Agriculture as to whether certain individuals specified in the provisions should be denied access to or granted limited access to specific agents. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to E:\FR\FM\26APN1.SGM 26APN1

Agencies

[Federal Register Volume 86, Number 78 (Monday, April 26, 2021)]
[Notices]
[Pages 22070-22071]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08586]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[OMB Number 1117-NEW]


Agency Information Collection Activities; Proposed eCollection, 
eComments Requested; New Proposed Collection Exempt Chemical 
Preparations Application

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 60-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration (DEA), Department of 
Justice (DOJ), will be submitting the following information collection 
request to the Office of Management and Budget (OMB) for review and 
approval in accordance with the Paperwork Reduction Act of 1995.

DATES: Comments are encouraged and will be accepted for 60 days until 
June 25, 2021.

FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated 
public burden or associated response time, suggestions, or need a copy 
of the proposed information collection instrument with instructions or 
additional information, please contact Scott A. Brinks, Diversion 
Control Division, Drug Enforcement Administration; Mailing Address: 
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 
362-3261.

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of 
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other forms of information technology, e.g., 
permitting electronic submission of responses.


[[Page 22071]]



Overview of This Information Collection

    1. Type of Information Collection: New collection.
    2. Title of the Form/Collection: Exempt Chemical Preparations 
Application.
    3. The agency form number, if any, and the applicable component of 
the Department sponsoring the collection: N/A. The applicable component 
within the Department of Justice is the Drug Enforcement 
Administration, Diversion Control Division.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Affected public: Business or other for-profit.
    Abstract: Pursuant to 21 U.S.C. 811(g)(3)(B), DEA (by delegation of 
authority from the Attorney General) may, by regulation, exempt from 
specific provisions of the Controlled Substances Act (CSA) any 
compound, mixture, or preparation containing any controlled substance, 
which is not for administration to a human being or animal, and which 
is packaged in a certain manner, so that as packaged it does not 
present any significant potential for abuse. In accordance with 21 CFR 
1308.23(f), the Administrator (or the Deputy Assistant Administrator), 
at any time, may revoke or modify any exemption granted pursuant to 21 
CFR 1308.23; modify or revoke the criteria by which exemptions are 
granted; and modify the scope of exemptions.
    5. An estimate of the total number of respondents and the amount of 
time estimated for an average respondent to respond: The below table 
presents information regarding the number of respondents, responses and 
associated burden hours.

----------------------------------------------------------------------------------------------------------------
                         Labor category                               Number         % of time         Cost
----------------------------------------------------------------------------------------------------------------
Chemist, GS-14, step 5..........................................               3              30        $200,967
Unit Chief, GS-14, step 5.......................................               1               5          11,165
Section Chief, GS-15, step 5....................................               1               1           2,627
                                                                 -----------------------------------------------
    Total.......................................................  ..............  ..............         214,758
----------------------------------------------------------------------------------------------------------------

    6. An estimate of the total public burden (in hours) associated 
with the proposed collection: DEA estimates that this collection takes 
2,093 annual burden hours.
    If additional information is required please contact: Melody 
Braswell, Department Clearance Officer, United States Department of 
Justice, Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC 
20530.

    Dated: April 21, 2021.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2021-08586 Filed 4-23-21; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.